Discover
ASBP
Aspire Biopharma Holdings, Inc.
8.11
1 x 8.05
5 x 9.00
bid
ask
-
0.52
6.03%
3 @ 04:00 PM
8.36 +0.25 (3.08%)
| Ytd | 53.60% | |
| 1y | -46.08% |
8.00
day range
8.46
0.11
52 week range
15.88
| Open | 8.46 | Prev Close | 8.63 | Low | 8.00 | High | 8.46 | Mkt Cap | 11.37M |
| Vol | 20.29K | Avg Vol | 31.46K | EPS | -30.89 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 8.55 | 200-d Avg | 4.79 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 63.10K | ||
| Revenues (USD) | 63.10K | ||
| Cost of Revenue | 93.19K | ||
| Gross Profit | -30.09K | ||
| Operating Expenses | 2.65M | ||
| Research and Development Expense | 233.48K | ||
| Selling, General and Administrative Expense | 2.19M | ||
| Operating Income | -2.68M | ||
| Net Income | -1.27M | ||
| Net Income Common Stock | -1.27M | ||
| Net Income Common Stock (USD) | -1.27M | ||
| Consolidated Income | -1.27M | ||
| Earnings per Basic Share | -1.22 | ||
| Earnings per Basic Share (USD) | -1.22 | ||
| Earnings per Diluted Share | -1.22 | ||
| Earning Before Interest & Taxes (EBIT) | -1.27M | ||
| Earning Before Interest & Taxes (USD) | -1.27M | ||
| Weighted Average Shares | 1.04M | ||
| Weighted Average Shares Diluted | 1.04M | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.17M | ||
| Cash and Equivalents (USD) | 12.17M | ||
| Current Assets | 13.47M | ||
| Total Assets | 13.54M | ||
| Current Liabilities | 1.69M | ||
| Total Liabilities | 1.78M | ||
| Accumulated Retained Earnings (Deficit) | -31.75M | ||
| Shareholders Equity | 11.76M | ||
| Shareholders Equity (USD) | 11.76M | ||
| Assets Non-Current | 75.00K | ||
| Inventory | 288.45K | ||
| Liabilities Non-Current | 96.53K | ||
| Trade and Non-Trade Payables | 972.11K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 8.43M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.31M | ||
| Issuance (Repayment) of Debt Securities | -499.21K | ||
| Net Cash Flow from Operations | -2.12M | ||
| Share Based Compensation | 144.09K | ||